184 related articles for article (PubMed ID: 18070842)
1. Risk factors for and correlates of poststroke depression following discontinuation of antidepressants.
Fiedorowicz JG; Takezawa K; Robinson RG
J Neuropsychiatry Clin Neurosci; 2007; 19(4):399-405. PubMed ID: 18070842
[TBL] [Abstract][Full Text] [Related]
2. Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up.
Narushima K; Kosier JT; Robinson RG
J Nerv Ment Dis; 2002 May; 190(5):296-303. PubMed ID: 12011609
[TBL] [Abstract][Full Text] [Related]
3. Mortality and poststroke depression: a placebo-controlled trial of antidepressants.
Jorge RE; Robinson RG; Arndt S; Starkstein S
Am J Psychiatry; 2003 Oct; 160(10):1823-9. PubMed ID: 14514497
[TBL] [Abstract][Full Text] [Related]
4. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.
Robinson RG; Schultz SK; Castillo C; Kopel T; Kosier JT; Newman RM; Curdue K; Petracca G; Starkstein SE
Am J Psychiatry; 2000 Mar; 157(3):351-9. PubMed ID: 10698809
[TBL] [Abstract][Full Text] [Related]
5. Effect of antidepressants on the course of disability following stroke.
Mikami K; Jorge RE; Adams HP; Davis PH; Leira EC; Jang M; Robinson RG
Am J Geriatr Psychiatry; 2011 Dec; 19(12):1007-15. PubMed ID: 21358384
[TBL] [Abstract][Full Text] [Related]
6. Aggressive behavior in patients with stroke: association with psychopathology and results of antidepressant treatment on aggression.
Chan KL; Campayo A; Moser DJ; Arndt S; Robinson RG
Arch Phys Med Rehabil; 2006 Jun; 87(6):793-8. PubMed ID: 16731214
[TBL] [Abstract][Full Text] [Related]
7. Poststroke depression.
Franco K; Malhotra S
Am J Psychiatry; 2001 Apr; 158(4):658-60. PubMed ID: 11282720
[No Abstract] [Full Text] [Related]
8. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
Joyce PR; Mulder RT; McKenzie JM; Luty SE; Cloninger CR
Depress Anxiety; 2004; 19(3):180-6. PubMed ID: 15129420
[TBL] [Abstract][Full Text] [Related]
9. Does cognitive recovery after treatment of poststroke depression last? A 2-year follow-up of cognitive function associated with poststroke depression.
Narushima K; Chan KL; Kosier JT; Robinson RG
Am J Psychiatry; 2003 Jun; 160(6):1157-62. PubMed ID: 12777275
[TBL] [Abstract][Full Text] [Related]
10. The effect of remission of poststroke depression on activities of daily living in a double-blind randomized treatment study.
Chemerinski E; Robinson RG; Arndt S; Kosier JT
J Nerv Ment Dis; 2001 Jul; 189(7):421-5. PubMed ID: 11504318
[TBL] [Abstract][Full Text] [Related]
11. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
[TBL] [Abstract][Full Text] [Related]
12. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
Diaz A; Fouilloux C; Ortiz S
Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
[No Abstract] [Full Text] [Related]
13. Thyroid indices and response to fluoxetine and nortriptyline in major depression.
Gendall KA; Joyce PR; Mulder RT; Luty SE
J Psychopharmacol; 2003 Dec; 17(4):431-7. PubMed ID: 14870956
[TBL] [Abstract][Full Text] [Related]
14. Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression: merged analysis of nortriptyline trials.
Kimura M; Tateno A; Robinson RG
Am J Geriatr Psychiatry; 2003; 11(3):320-7. PubMed ID: 12724111
[TBL] [Abstract][Full Text] [Related]
15. Depression and cerebrovascular disease.
Robinson RG; Morris PL; Fedoroff JP
J Clin Psychiatry; 1990 Jul; 51 Suppl():26-31; discussion 32-3. PubMed ID: 2195010
[TBL] [Abstract][Full Text] [Related]
16. A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender.
Joyce PR; Mulder RT; Luty SE; McKenzie JM; Rae AM
Acta Psychiatr Scand; 2003 Jul; 108(1):20-3. PubMed ID: 12807373
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine versus moclobemide: cross-comparison between the time courses of improvement.
Stassen HH; Angst J; Delini-Stula A
Pharmacopsychiatry; 1999 Mar; 32(2):56-60. PubMed ID: 10333163
[TBL] [Abstract][Full Text] [Related]
18. Fluoxetine (prozac) in depresion of adults.
Kocur J; Rydzynski Z; Duszyk S; Gruszczynski W; Trendak W
Homeost Health Dis; 1991; 33(5-6):295. PubMed ID: 18265505
[No Abstract] [Full Text] [Related]
19. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
[TBL] [Abstract][Full Text] [Related]
20. Eighteen months of drug treatment for depression: predicting relapse and recovery.
Mulder RT; Frampton CM; Luty SE; Joyce PR
J Affect Disord; 2009 Apr; 114(1-3):263-70. PubMed ID: 18805590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
